Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis

References

• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, Pond GR, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93
   PubMed Web of Science ®Google Scholar
• Conti F, Rezai S, Valesini G. Vaccination and rheumatic diseases: is there still a dilemma? Curr Rheumatol Rev 2007;3:79-91
   Google Scholar
• Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008;8:124-8
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:36-44
   PubMed Web of Science ®Google Scholar
• Manzoli L, Ioannidis JP, Flacco ME, et al. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother 2012;8:851-62
   PubMed Web of Science ®Google Scholar
• Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010;49:1815-27
   PubMed Web of Science ®Google Scholar
• Garrido Lopez BC, Navarro Compain MV, Navarro Sarabia F. Vaccines and chemo-prophylaxis in rheumatoid arthritis: is a vaccine calendar necessary? Reumatol Clin 2011;7:412-16
   PubMedGoogle Scholar
• Oren S, Mandelboim M, Braun-Moscovici Y, et al. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 2008;67:937-41
   PubMed Web of Science ®Google Scholar
• França IL, Ribeiro AC, Aikawa NE, et al. TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. Rheumatology (Oxford) 2012;51:2091-8
   PubMed Web of Science ®Google Scholar
• Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001;16:309-18
   PubMed Web of Science ®Google Scholar
• Kwong JC, Vasa PP, Campitelli MA, et al. Risk of Guillain–Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013;13:769-76
   PubMed Web of Science ®Google Scholar
• Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005;38:235-45
   PubMed Web of Science ®Google Scholar
• Salemi S, D’Amelio R. Could autoimmunity be induced by vaccination? Int Rev Immunol 2010;29:247-69
   PubMed Web of Science ®Google Scholar
• Perdan-Pirkmajer K, Thallinger GG, Snoj N, et al. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus 2012;21:175-83
   PubMed Web of Science ®Google Scholar
• Basra G, Jajoria P, Gonzalez E. Rheumatoid arthritis and swine influenza vaccine: a case report. Case Rep Rheum 2012;2012:3
   Google Scholar
• Herron A, Dettleff G, Hixon B, et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 1979;242:53-6
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Nacionales DC, Akaogi J, et al. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 2004;58:325-37
   PubMed Web of Science ®Google Scholar
• Ribeiro AC, Guedes LK, Moraes JC, et al. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ann Rheum Dis 2011;70:2144-7
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
   PubMed Web of Science ®Google Scholar
• Fransen J, Stucki G, van Riel PLCM. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care Res (Hoboken) 2003;49:S214-S24
   Google Scholar
• Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and under taking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org [Last accessed 28 September 2016]
   Google Scholar
• The Cochrane Collaboration. Available at: http://www.cochrane.org/[Last accessed 28 September 2016]
   Google Scholar
• Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25:3443-57
   PubMed Web of Science ®Google Scholar
• Adler S, Krivine A, Weix J, et al. Protective effect of A/H1N1 vaccination in immune-mediated disease – a prospectively controlled vaccination study. Rheumatology (Oxford) 2012;51:695-700
   PubMed Web of Science ®Google Scholar
• Chalmers A, Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203-6
   PubMed Web of Science ®Google Scholar
• Del Porto F, Laganà B, Biselli R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006;24:3217-23
   PubMed Web of Science ®Google Scholar
• Elkayam O, Amir S, Mendelson E, et al. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken) 2011;63:1062-7
   PubMed Web of Science ®Google Scholar
• Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFalpha blockers. Ann Rheum Dis 2006;65:191-4
   PubMed Web of Science ®Google Scholar
• Kubota T, Nii T, Nanki T, et al. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol 2007;17:531-3
   PubMedGoogle Scholar
• Milanetti F, Germano V, Nisini R, et al. Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals. Clin Exp Immunol 2014;177:287-94
   PubMed Web of Science ®Google Scholar
• Salemi S, Picchianti-Diamanti A, Germano V, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF alpha blockers: safety and immunogenicity. Clin Immunol 2010;134:113-20
   PubMed Web of Science ®Google Scholar
• van Assen S, Holvast A, Benne CA, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 2010;62:75-81
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Abrams KR, Batham S, et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis 2011;11:91-101
   PubMed Web of Science ®Google Scholar
• The Department of Health. Available at: https://www.gov.uk/government/organisations/department-of-health [Last accessed 28 September 2016]
   Google Scholar
• O’Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-602
   PubMed Web of Science ®Google Scholar
• Kogure T, Harada N, Tatsumi T, Fujinaga H. Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis. Clin Rheumatol 2014;33:323-8
   PubMed Web of Science ®Google Scholar
• Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin 2011;27:11-20
   PubMed Web of Science ®Google Scholar
• van der Kooij SM, Allaart CF, Dijkmans BA, Breedveld FC. Innovative treatment strategies for patients with rheumatoid arthritis. Curr Opin Rheumatol 2008;20:287-94
   PubMed Web of Science ®Google Scholar
• Germano V, Cattaruzza MS, Osborn J, et al. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists. J Transl Med 2014;12:77
   PubMed Web of Science ®Google Scholar
• Seasonal Flu Information for Rheumatology Health Professionals. Available at: http://www.cdc.gov/arthritis/rheum-flu.htm [Last accessed 28 September 2016]
   Google Scholar
• McElhaney JE, Beran J, Devaster JM, et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis 2013;13:485-96
   PubMed Web of Science ®Google Scholar
• Dormitzer P, Tsai T, Del Giudice G. New technologies for influenza vaccines. Hum Vaccin Immunother 2011;8:45-58
   Web of Science ®Google Scholar
• Sengler C, Niewerth M, Kallinich T, et al. Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases. Clin Rheumatol 2014;33:137-9
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Anton A, Ibanez D, Gladman DD. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:1517-20
   PubMed Web of Science ®Google Scholar
• Salemi S, D’Amelio R. Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol 2010;29:270-314
   PubMed Web of Science ®Google Scholar
• Baxter R, Bakshi N, Fireman B, et al. Lack of association of Guillain–Barré Syndrome with vaccinations. Clin Infect Dis 2013;57:197-204
   PubMed Web of Science ®Google Scholar
• Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain–Barré Syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006;166:1301-4
   PubMed Web of Science ®Google Scholar